期刊文献+

补体抑制免疫复合物沉淀作用的实验研究 被引量:1

Experimental study on inhibition of immune precipitation by complement
下载PDF
导出
摘要 本文以辣根过氧化物酶(PO)作抗原与相应抗体(抗-PO)混合,加入血清,对血清补体抑制免疫复合物沉淀作用(IIPC)进行了研究。结果表明,在抗原抗体最适比例时形成免疫复合物最多;原血清及1∶2稀释血清IIPC最强,OD值为0.57和0.54,血清的进一步稀释对IIPC有一定影响;孵育时间以30min最宜,OD值为0.56;离心时间在25~45min时OD值最大,为0.50~0.56;在最适条件下,正常人混合血清OD值为0.49;56℃30min灭活血清为0.14;50℃15min处理血清为0.38;ED-TA处理血清为0.09,EGTA处理血清为0.21;对20例健康人血清IIPC测定结果为0.39~0.62,平均0.48±0.07。表明正常血清补体对免疫复合物的沉淀有明显抑制作用,各种因素处理血清对IIPC均有一定影响,而以56℃30min和EDTA处理血清最明显。文中还对该法的影响因素进行了讨论。 In this paper, a method for measuring inhibition of immune precipitation by complement(IIPC) using peroxidase (PO) as a antigen was studies. The results showed that immune complex of PO and anti-PO rabbit IgG at equivalence could form a great quantity of precipitation. OD values were 0. 57and 0. 54 in non and diluted serum(1: 2 ), 0. 56 in 30 minutes incubation time, and 0. 50~0. 56 in 25~45 minutes centrifugation time. OD value of normal individuals mixture seruml the serum of heating to 56℃ for 30 minutes, 50℃ 15 minutes, and treated by ethylenediamine tetracetate (EDTA), ethyleneglycol tetracetate(EGTA) were 0. 49, 0. 14, 0. 38, 0. 09, 0. 21 respectively. IIPC of 20 normal persons was 0. 48 ± 0. 07 (0. 39 ~ 0. 62). These results indicate that normal serum markedly inhibites precipitation of immune complex and many agents may block IIPC of serum, especially 56℃ for 30 minutes and EDTA. The various factors of inhibiting IIPC are discussed in the paper.
出处 《河南科技大学学报(医学版)》 1994年第1期3-7,共5页 Journal of Henan University of Science & Technology:Medical Science
基金 河南省卫生厅资助
关键词 补体 免疫复合物 补体对免疫沉淀的抑制作用 辣根过氧化物酶 complenent immune complex inhibition of immune precipitation by complement peroxidase
  • 相关文献

参考文献9

  • 1田景先,康洋,王文余.补体对免疫复合物的作用[J].国外医学(免疫学分册),1989,12(5):236-238. 被引量:7
  • 2王连芳,崔燕燕,张英,郭玲琳,张利增.放免法检测血清补体免疫沉淀抑制作用的研究[J]中国免疫学杂志,1988(01).
  • 3姜海翔 顾新焕 段恕诚.血清补体防止免疫复合物沉淀作用的研究[J].中国免疫学杂志,1985,1(5):31-33.
  • 4Naama JK,Holme,E,Hamilton E,et al.Preventionof immune precipitation by purified componenttsof the alternative pathway. Clinical and Experimental Immunology . 1985
  • 5Naama JK,Hamilton AO,Yeung-Laiwah AC,etal.Prevention of immune precipitation by purifiedclassical pathway complement components. Clinical and Experimental Immunology . 1984
  • 6Schifferli JA,Bartolotti SR,Peters DK.Inhibitinon ofimmune precipitation by complement. Clinical and Experimental Immunology . 1980
  • 7Schifferli JA,Woo P,Peters Dk.Complement-mediatedinhibition of immune precipitation.I. Role of theclassical and alternative pathways. Clinical and Experimental Immunology . 1982
  • 8Naama JK,Mitchell WS,Zoma A,et al.Complement-mediated inhibition of immune precipitation inpatlents with immune complex diseases. Clinical and Experimental Immunology . 1983
  • 9Schifferil JA.Steiger G, Sehapira M.The role ofC1,C1-inactivator and C4 in modulating immune precipitation. Clinical and Experimental Immunology . 1985

共引文献9

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部